A recent Form 4 filing with the Securities and Exchange Commission disclosed that Klaviyo's director, Susan St. Ledger, sold a portion of her holdings in the company's common stock.
Specifically, on May 18, 2026, Ms. St. Ledger disposed of 9,334 shares of Series A Common Stock belonging to Klaviyo, Inc., which trades under the ticker symbol NYSE:KVYO. The sale was executed at a price point of $14.27 per share, resulting in a total divestment value of $133,196.
This reported transaction takes place amid noticeable fluctuations in the stock's valuation. Over the past year, the stock has experienced a decline of 54%. Despite this historical dip, available analysis suggests that the company may currently be undervalued at its market price, with shares trading below what is considered their Fair Value.
Prior to divesting these shares, Ms. St. Ledger had acquired an equivalent amount of stock through a conversion process. She converted 9,334 shares of Series B Common Stock into the corresponding number of Series A Common Stock shares. The structure governing the Series B Common Stock allows each share to convert into one share of Series A Common Stock at the holder's option or upon the occurrence of specific corporate events. Crucially, this conversion mechanism carries no expiration date.
All transactions involving these stock movements were conducted in compliance with a Rule 10b5-1 trading plan. This established plan was initially adopted by Ms. St. Ledger on June 11, 2025.
Current Holdings and Financial Context
Following the recent sale, Ms. St. Ledger's direct holdings in Series A Common Stock amount to 10,939 shares. This total figure comprises two components: 5,119 shares of Series A Common Stock that are immediately held, alongside 5,820 unvested restricted stock units. These restricted stock units represent a contingent right, meaning they will grant the holder one share of Series A Common Stock only after fulfilling vesting and settlement requirements.
In addition to her Series A holdings, Ms. St. Ledger maintains ownership of 50,166 shares of Series B Common Stock.
Q1 2026 Performance and Analyst Reactions
The transaction activity is set against a backdrop of recent corporate financial reporting for Klaviyo Inc. The company announced its first quarter results for 2026, which surpassed market expectations across key metrics. Specifically, the firm reported earnings per share (EPS) of $0.22. This figure exceeded the projected EPS estimate of $0.20. Furthermore, revenue reached $358 million, surpassing the anticipated revenue level of $348.6 million.
Despite these demonstrably positive financial outcomes, the reaction from external analysts has been mixed and cautious. Several investment firms have adjusted their price targets for Klaviyo. Stifel, for example, lowered its target price to $28 from a previous estimate of $35. The firm cited concerns over guidance deceleration while maintaining an overall Buy rating on the stock.
Similarly, Piper Sandler reduced its price target to $26 from $30. This reduction was based on expressed concerns regarding margin performance, although they continued to assign an Overweight rating to the company.
Market Insights and Valuation
The current market activity suggests a divergence between fundamental operational strength and analyst sentiment. While Klaviyo achieved strong Q1 results, indicating solid execution in its core business areas, the adjustments in price targets by major analysts highlight persistent concerns regarding future growth trajectories and profitability margins.
The stock trading data provided shows KVYO closed at $14.95 after hours on a specific date, representing a decrease of $0.16 (-1.06%) from the prior close. This indicates recent downward pressure despite strong earnings announcements.